launchesanalysis

123 results found.

Top Stocks matching your search for "launches analysis"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 4, 2022

Anavex shares could get Launched 100% or better jist on Monday!

Nov, 16, 2022

Launch pad feeling firm.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

I think that's a good number considering all t... See more

Jan, 29, 2023

We have built what we consider to be a best-in-cla... See more

Image with triangles

Divihomes is Now Live

Check out our new advanced search tool that can help you find the best home services in your area.

Search & Match

Instant Communication

Phone Image with DiviHomes website

Unbiased Reviews

100% Free

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 20, 2023

$SLRX Ready for launch!🚀

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 4, 2022

Anavex shares could get Launched 100% or better jist on Monday!

Nov, 16, 2022

Launch pad feeling firm.

Oct, 6, 2022

$AVXL I must say that it is nice and comforting to see PR like ANVS just did to say that FDA approves phases launch and protocols.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 27, 2023

I think that's a good number considering all the work that goes into launching a product.

Jan, 29, 2023

We have built what we consider to be a best-in-class team to support this launch, as well as a robust patient support program designed to aid in accessing BRIUMVI at all points through the treatment journey.

Dec, 30, 2022

$TGTX successfully on time launch in Q1 2023 and EU approval mid year, we will be back to highs.

Dec, 29, 2022

$TGTX rocket launch 🚀

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 20, 2023

$SLRX Ready for launch!🚀